Moderna, Inc.

Biological Products, (No Diagnostic Substances)·CAMBRIDGE, MA·FY end 12/31·CIK 1682852

CEO Pay Ratio

89:1

Stéphane Bancel

CEO Total Comp

$157.2K

Stéphane Bancel

Median Employee

$225,053

Revenue

$1.9B

FY 2025

Net Income

-$2.8B

FY 2025

Free Cash Flow

-$2.1B

FY 2025

Net Margin

-145.2%

Insider Net (180d)

-$9.5M

0 buys / 5 sales

CEO Pay Accountability

CEO comp as % of net income

-0.01%

For every $1,000 of profit, $-0.06 flows to the CEO.

CEO comp as % of buybacks

7.86%

CEO comp equals 78.6‰ of cash returned to shareholders via buybacks.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$1.9B	$3.2B	$6.8B	$19.3B	$18.5B
Gross Profit	—	—	—	—	—	—
Operating Income	-$3.1B	-$3.9B	-$4.2B	$9.4B	$13.3B
Net Income	-$2.8B	-$3.6B	-$4.7B	$8.4B	$12.2B
Operating CF	-$1.9B	-$3.0B	-$3.1B	$5.0B	$13.6B
Capex	$192.0M	$1.1B	$707.0M	$400.0M	$284.0M
Free Cash Flow	-$2.1B	-$4.1B	-$3.8B	$4.6B	$13.3B
Buybacks	$2.0M	$0	$1.2B	$3.3B	$857.0M
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	-158.1%	-121.9%	-61.9%	48.9%	72.0%
Net Margin	-145.2%	-110.0%	-68.8%	43.4%	66.1%
FCF Margin	-106.2%	-125.3%	-55.9%	23.8%	72.2%
R&D / Revenue	161.1%	140.4%	70.8%	17.1%	10.8%
Effective Tax	-2.0%	1.3%	-19.6%	12.7%	8.2%
Debt / Equity	0.07	—	—	—	—	—
Buybacks / FCF	-0.1%	0.0%	-30.1%	72.7%	6.4%

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Stéphane BancelChief Executive Officer	$1.7M	—	$6.9M	$4.3M	$6.9M	$157.2K
James MockChief Financial Officer	$852.2K	—	$2.5M	$1.3M	$1.2M	$15.8K
Shannon Thyme KlingerChief Legal Officer and Corporate Secretary	$852.2K	—	$2.1M	$1.3M	$1.1M	$15.8K
Stephen HogeM.D. President	$1.3M	—	$9.2M	$3.0M	$4.6M	$15.8K